| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.043 | 0.3 |